JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 36 No. 2 176-179
© 1995 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burt, R. W.
Right arrow Articles by Witt, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burt, R. W.
Right arrow Articles by Witt, R. M.

Direct Comparison of Fluorine-18-FDG SPECT, Fluorine-18-FDG PET and Rest Thallium-201 SPECT for Detection of Myocardial Viability

Robert W. Burt, Orrin W. Perkins, Bernard E. Oppenheim, Donald S. Schauwecker, Leon Stein, Henry N. Wellman and Robert M. Witt

Division of Nuclear Medicine, Department of Radiology, and Division of Cardiology, Richard L. Roudebush Veteran's Affairs Medical Center and Indiana University School of Medicine, Indianapolis, Indiana

Correspondence: For correspondence or reprints contact: Robert W. Burt, MD, Nuclear Medicine Service, 1481 West 10th Street, Indianapolis, IN 46202.

ABSTRACT

Twenty consecutive patients were evaluated for presumptive myocardial viability using rest Tl-SPECT, FDG-PET and FDG-SPECT. The FDG studies were performed after rest Tl-SPECT to guide intervention or medical management. Methods: Twenty patients with proven coronary artery disease, either known or suspected to have previous myocardial infarction and persistent perfusion defects shown by rest reinjection Tl-SPECT, underwent FDG-PET and subsequent FDG-SPECT with a three-detector SPECT camera. FDG-PET and SPECT images were compared by five observers to determine if any fixed thallium segments were visualized by either FDG imaging method. Results: Thirteen of 60 fixed segments were shown probably viable by FDG-SPECT (8 of 20 patients) and 14 of 60 by FDG PET (7 of 20 patients). Two patients had fixed thallium segments found probably viable with FDG by SPECT alone and one by PET alone. Conclusion: FDG is shown to provide additional information about myocardial viability. Both SPECT, using a three-detector camera, and PET with a specialized instrument are equally effective for imaging FDG in this application.

Key Words: fluorodeoxyglucose • SPECT • PET • myocardial viability • thallium




This article has been cited by other articles:


Home page
JNMHome page
S. Graf, M. Gyongyosi, A. Khorsand, S. G. Nekolla, C. Pirich, K. Kletter, R. Dudczak, D. Glogar, G. Porenta, and H. Sochor
Electromechanical Properties of Perfusion/Metabolism Mismatch: Comparison of Nonfluoroscopic Electroanatomic Mapping with 18F-FDG PET
J. Nucl. Med., October 1, 2004; 45(10): 1611 - 1618.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S.R. Underwood, J. J Bax, J. v. Dahl, M. Y Henein, A. C van Rossum, E. R Schwarz, J.-L. Vanoverschelde, E. E.v. d. Wall, and W. Wijns
Imaging techniques for the assessment of myocardial hibernation: Report of a Study Group of the European Society of Cardiology
Eur. Heart J., May 2, 2004; 25(10): 815 - 836.
[Abstract] [Full Text] [PDF]


Home page
J. Nucl. Med. Technol.Home page
R. A. Pagnanelli, M. W. Hanson, T. Turkington, R. E. Coleman, and S. Borges-Neto
Gated 99mTc-Tetrofosmin and 18F-FDG Studies: A Comparison of Single-Acquisition and Separate-Acquisition Protocols
J. Nucl. Med. Technol., December 1, 2002; 30(4): 175 - 178.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
G. D. Vitale, R. A. deKemp, T. D. Ruddy, K. Williams, and R. S.B. Beanlands
Myocardial Glucose Utilization and Optimization of 18F-FDG PET Imaging in Patients with Non-Insulin-Dependent Diabetes Mellitus, Coronary Artery Disease, and Left Ventricular Dysfunction
J. Nucl. Med., December 1, 2001; 42(12): 1730 - 1736.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
I. Matsunari, T. Yoneyama, S. Kanayama, M. Matsudaira, K. Nakajima, J. Taki, S. G. Nekolla, N. Tonami, and K. Hisada
Phantom Studies for Estimation of Defect Size on Cardiac 18F SPECT and PET: Implications for Myocardial Viability Assessment
J. Nucl. Med., October 1, 2001; 42(10): 1579 - 1585.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
H. Sato, T. Iwasaki, T. Toyama, Y. Kaneko, T. Inoue, K. Endo, and R. Nagai
Prediction of Functional Recovery After Revascularization in Coronary Artery Disease Using 18F-FDG and 123I-BMIPP SPECT*
Chest, January 1, 2000; 117(1): 65 - 72.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
H. Jadvar, H. W. Strauss, and G. M. Segall
SPECT and PET in the Evaluation of Coronary Artery Disease
RadioGraphics, July 1, 1999; 19(4): 915 - 926.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. E. Udelson
Steps Forward in the Assessment of Myocardial Viability in Left Ventricular Dysfunction
Circulation, March 10, 1998; 97(9): 833 - 838.
[Full Text] [PDF]


Home page
CirculationHome page
G. Srinivasan, A. N. Kitsiou, S. L. Bacharach, M. L. Bartlett, C. Miller-Davis, and V. Dilsizian
[18F]Fluorodeoxyglucose Single Photon Emission Computed Tomography : Can It Replace PET and Thallium SPECT for the Assessment of Myocardial Viability?
Circulation, March 10, 1998; 97(9): 843 - 850.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. F. Di Carli, F. Asgarzadie, H. R. Schelbert, R. C. Brunken, H. Laks, M. E. Phelps, and J. Maddahi
Quantitative Relation Between Myocardial Viability and Improvement in Heart Failure Symptoms After Revascularization in Patients With Ischemic Cardiomyopathy
Circulation, December 15, 1995; 92(12): 3436 - 3444.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1995 by the Society of Nuclear Medicine.